Logo En IconLogo Mark IconIcelandic Intellectual Property Office

EP2992903

COMBINATION OF A NALOXOL-PEG CONJUGATE AND AN OPIOID AGONIST

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    29.9.2011
  • EP published:
    15.7.2020
  • EP application number:
    15188944.1
  • Max expiry date:
    28.9.2031
  • Title:
    COMBINATION OF A NALOXOL-PEG CONJUGATE AND AN OPIOID AGONIST

Timeline

Today
29.9.2011EP application
15.7.2020EP Publication

Owner

  • Name:
    AstraZeneca AB
  • Address:
    151 85 Södertälje, SE
  • Name:
    Nektar Therapeutics
  • Address:
    455 Mission Bay Boulevard Suite 100, San Francisco, CA 94158, US

Inventor

  • Name:
    ASLUND, Bengt Leonard
  • Address:
    151 85 Södertälje, SE
  • Name:
    AURELL, Carl-Johan
  • Address:
    151 85 Södertälje, SE
  • Name:
    BOHLIN, Martin Hans
  • Address:
    151 85 Södertälje, SE
  • Name:
    SEBHATU, Tesfai
  • Address:
    151 85 Södertälje, SE
  • Name:
    YMEN, Bo Ingvar
  • Address:
    151 85 Södertälje, SE
  • Name:
    HEALY, Eric Thomas
  • Address:
    San Francisco, CA 94158, US
  • Name:
    JENSEN, David Richard
  • Address:
    San Francisco, CA 94158, US
  • Name:
    JONAITIS, David Thomas
  • Address:
    West Lafayette, IN 47906-1076, US
  • Name:
    PARENT, Stephan
  • Address:
    West Lafayette, IN 47906-1076, US

Priority

  • Number:
    388501 P
  • Date:
    30.9.2010
  • Country:
    US

Classification

  • Categories:
    A61K 47/60, A61K 45/06, A61P 39/00, C07D 489/04

Upload documents